Recent Finacing
Recent Raise
Evgen is a Liverpool-based pharmaceutical company developing Sulforadex, a patented synthetic sulforaphane formulation undergoing preclinical development and planned clinical trials for prevention and treatment of prostate and other cancers.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
